306 related articles for article (PubMed ID: 31889657)
1. Editor's Choice - Drug Coated Balloon Angioplasty vs. Standard Percutaneous Transluminal Angioplasty in Below the Knee Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.
Ipema J; Huizing E; Schreve MA; de Vries JPM; Ünlü Ç
Eur J Vasc Endovasc Surg; 2020 Feb; 59(2):265-275. PubMed ID: 31889657
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
[No Abstract] [Full Text] [Related]
3. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
5. Vessel Preparation in Infrapopliteal Arterial Disease: A Systematic Review and Meta-Analysis.
Nugteren MJ; Welling RHA; Bakker OJ; Ünlü Ç; Hazenberg CEVB
J Endovasc Ther; 2024 Apr; 31(2):191-202. PubMed ID: 36062761
[TBL] [Abstract][Full Text] [Related]
6. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
7. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization.
Zhang J; Xu X; Kong J; Xu R; Fan X; Chen J; Zheng X; Ma B; Sun M; Ye Z; Liu P
Vasc Endovascular Surg; 2017 Feb; 51(2):72-83. PubMed ID: 28103754
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G
Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis Comparing Drug-Coated Balloons and Percutaneous Transluminal Angioplasty for Infrapopliteal Artery Disease.
Barbarawi M; Qazi AH; Lee J; Barbarawi O; Al-Abdouh A; Mhanna M; Vashist A
Am J Cardiol; 2022 Nov; 183():115-121. PubMed ID: 36116953
[TBL] [Abstract][Full Text] [Related]
11. Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial.
Mustapha JA; Brodmann M; Geraghty PJ; Saab F; Settlage RA; Jaff MR;
J Invasive Cardiol; 2019 Aug; 31(8):205-211. PubMed ID: 31368893
[TBL] [Abstract][Full Text] [Related]
12. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
13. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions: the IN.PACT BTK randomised trial.
Liistro F; Weinberg I; Almonacid Popma A; Shishehbor MH; Deckers S; Micari A
EuroIntervention; 2022 Apr; 17(17):e1445-e1454. PubMed ID: 34602386
[TBL] [Abstract][Full Text] [Related]
15. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
Catheter Cardiovasc Interv; 2019 Mar; 93(4):664-672. PubMed ID: 30747489
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
20. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
